Innova Captab Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Thu Apr 09 2026

Innova Captab (NSE: INNOVACAP) is preparing to announce its Q4 FY26 financial results for the period ended March 31, 2026. The board of directors is scheduled to meet on May 2026 (Expected) to approve the audited statements and consider a final dividend recommendation. With the stock at Rs 680 — against a 52-week high of Rs 950 and 1-year return of -22% — the Q4 FY26 results will be a pivotal event for investors.

Analyst estimates for Q4 FY26 revenue stand at Rs 330-360 Cr, with PAT expectations of Rs 42-52 Cr and margin projections of EBITDA 18-20%. This article covers the Innova Captab Q4 results 2026 date, earnings estimates, five key performance factors, five risks, analyst ratings, and investor FAQs.

Table of Contents

Innova Captab Q4 Results 2026 Date

Get free investment predictions and live Q4 result alerts on Univest.

Company	Results Date	Article
TCS	April 9, 2026	Preview on Univest
Infosys	April 23, 2026	Preview on Univest
Innova Captab	May 2026 (Expected)	This article

Why This Quarter Matters

Innova Captab enters Q4 FY26 with expectations of 12-16% YoY revenue growth. Q4 determines full-year FY26 performance, sets FY27 estimate baselines, and triggers final dividend announcements. At a 1-year return of -22%, this quarter’s results and FY27 guidance will be critical for determining stock trajectory.

Innova Captab Q4 FY26 Earnings Estimates

Innova Captab Q4 FY26 analyst estimates. Source: MOFSL, YES Securities, JM Financial.

Access premium SEBI-registered research on Univest.

Metric	Q3 FY26 Actual	Q4 FY26 Estimate	Driver
Revenue	Rs 298 Cr	Rs 330-360 Cr	Volume + pricing
PAT	Rs 38 Cr	Rs 42-52 Cr	Operating leverage
Margin	EBITDA 18.4%	EBITDA 18-20%	Cost control
Key Growth Metric	Q3 trend	12-16% YoY revenue growth	Management execution
Dividend Estimate	—	Rs 2-4 per share	Board recommendation

Screen Innova Captab fundamentals on Univest Screener.

5 Key Factors That Will Drive Innova Captab Q4 FY26 Performance

Revenue Momentum

Analysts expect Rs 330-360 Cr in Q4 FY26 revenue versus Rs 298 Cr in Q3. Q4 is seasonally important for the Pharma/CDMO sector and the ability to convert the pipeline into recognised revenue will be the first performance test.

Margin Trajectory

Q4 FY26 margin expectations are EBITDA 18-20% versus EBITDA 18.4% in Q3. Input cost trends, employee expenses, and pricing power will determine whether the company can sustain or improve on Q3 levels.

PAT Quality

Net profit is estimated at Rs 42-52 Cr. Investors will assess whether PAT is driven by operational improvement or non-recurring items. A clean recurring profit print is most positively received by institutional investors.

Management Guidance for FY27

The most consequential output will be FY27 guidance — revenue growth bands, margin targets, and capex plans. Credible FY27 guidance carries significant weight for re-rating potential in the current macro environment.

Dividend Declaration

Innova Captab is expected to consider a final dividend of Rs 2-4 per share. The quantum signals management’s confidence in free cash flow generation and sets expectations for FY27 capital allocation.

5 Risks to Watch in Innova Captab Q4 FY26

US Tariff and Macro Headwinds

The 26% US reciprocal tariff on Indian goods has created macro uncertainty. For Innova Captab, indirect impacts include FII outflows and earnings estimate cuts if global demand slows.

Earnings Miss Risk

If Innova Captab’s Q4 FY26 results miss estimates, the stock could correct sharply. Investors should monitor revenue versus Rs 330-360 Cr and PAT versus Rs 42-52 Cr as the two primary watchpoints.

FY27 Guidance Below Consensus

If FY27 guidance falls below Street expectations, the stock may decline even if Q4 numbers are in line. Forward guidance carries more weight than the reported quarter currently.

FII Outflow Continuation

FIIs sold Rs 22,000 crore in Indian equities in a single week following the tariff announcement. Continued selling creates headwinds for Innova Captab regardless of fundamentals.

Sector Regulatory Risk

The Pharma/CDMO sector faces evolving regulatory frameworks. Policy changes that increase compliance costs or alter competitive dynamics could affect Innova Captab’s profitability.

Innova Captab Share Price and Analyst Ratings

Innova Captab share price snapshot and analyst ratings. Source: Brokerages, NSE data.

Innova Captab is trading at Rs 680 as of early April 2026, against a 52-week high of Rs 950 and 52-week low of Rs 540. Market cap stands at Rs 3,800 Cr.

Brokerage	Rating	Target Price	Thesis
MOFSL	Buy	Rs 850	CDMO + domestic formulation; anti-infective
YES Securities	Buy	Rs 830	Niche CDMO + branded generic scale
JM Financial	Add	Rs 800	Contract manufacturing growing 20%+
Emkay	Buy	Rs 815	High quality mid-cap CDMO franchise

Download the Univest iOS App or Univest Android App to track Innova Captab live and receive real-time Q4 result alerts.

Conclusion

Innova Captab Q4 FY26 results on May 2026 (Expected) will be a key event for Pharma/CDMO sector investors. Analysts project PAT of Rs 42-52 Cr and revenue of Rs 330-360 Cr. At Rs 680 with analyst targets from Rs 815 to Rs 850, FY27 guidance will be the most critical post-results catalyst.

For more Q4 FY26 previews, visit Univest Blogs.

Frequently Asked Questions

What is the Innova Captab Q4 results 2026 date?

The Innova Captab Q4 results 2026 date is May 2026 (Expected). The board will meet to approve audited Q4 FY26 financials and consider a final dividend recommendation.

What is the Innova Captab Q4 FY26 PAT estimate?

Analysts estimate Innova Captab Q4 FY26 PAT at Rs 42-52 Cr, based on revenue of Rs 330-360 Cr and margin of EBITDA 18-20%.

What is Innova Captab’s share price ahead of Q4 results?

Innova Captab is trading at Rs 680. The 52-week high is Rs 950 and low is Rs 540. The 1-year return is -22% and market cap is Rs 3,800 Cr.

Will Innova Captab declare a dividend in Q4 FY26?

Innova Captab is expected to consider a final dividend of Rs 2-4 per share at the Q4 FY26 board meeting on May 2026 (Expected).

Which analysts have a Buy rating on Innova Captab?

MOFSL (Buy, Rs 850), YES Securities (Buy, Rs 830), JM Financial (Add, Rs 800), Emkay (Buy, Rs 815) have positive ratings heading into Q4 FY26.

What were Innova Captab Q3 FY26 results?

Innova Captab reported Q3 FY26 revenue of Rs 298 Cr and PAT of Rs 38 Cr, with margin at EBITDA 18.4%.

When do TCS and Infosys announce Q4 results 2026?

TCS declared Q4 FY26 results on April 9, 2026. Infosys Q4 FY26 results are scheduled for April 23, 2026. Read both previews on Univest Blogs.

Is Innova Captab a good investment ahead of Q4 results?

This depends on your risk appetite. Innova Captab has compelling long-term factors alongside genuine near-term risks. Consult a SEBI-registered financial advisor before investing.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only. All financial data and analyst estimates are sourced from publicly available information. Verify before investing. Consult a SEBI-registered advisor before making investment decisions.